Orthopedics Market Consolidation 2017-2022: Who will not survive?
Will the $50 billion global orthopedics industry consolidate, decentralize, or undergo a bimodal transformation?
How will the current trends affect the major market segments?
Which companies will enter the market and which will not survive?
How will the current trends affect the major market segments?
Which companies will enter the market and which will not survive?
I. MARKET OVERVIEW
a. U.S.A
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Industry Consolidation
d. Managed Care
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Population Aging
b. Other Countries
II. MARKET SIZE AND GROWTH
a. Major Market Segments
b. Major Geographic Regions
III. EMERGING TECHNOLOGIES
a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/
Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies
IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS
Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses
V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS
The U.S. and international sales force size
Distribution approaches
Major promotional tactics
VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL KNOW-HOW INTERNALLY DEVELOPED AND ACQUIRED TECHNOLOGIES
Technical expertise in biotechnology, engineering and other pertinent fields
a. U.S.A
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Industry Consolidation
d. Managed Care
e. Hospitals
f. Admissions
g. Length of Stay
h. Industry Diversification
i. Physician Demographics
j. Population Aging
b. Other Countries
II. MARKET SIZE AND GROWTH
a. Major Market Segments
b. Major Geographic Regions
III. EMERGING TECHNOLOGIES
a. Overview
b. Resorbables
c. Bone Substitutes
d. Osteoinductive Agents/
Bone Graft Factors
e. Soft Tissue Repair And Replacement
f. Viscoelastics
g. Osteoporosis Therapies
IV. LEADING ORTHOPEDICS COMPANIES STRATEGIC DIRECTIONS
Business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and marketing strategies
Major strengths and weaknesses
V. LEADING ORTHOPEDICS COMPANIES MARKETING TACTICS
The U.S. and international sales force size
Distribution approaches
Major promotional tactics
VI. LEADING ORTHOPEDICS COMPANIES TECHNOLOGICAL KNOW-HOW INTERNALLY DEVELOPED AND ACQUIRED TECHNOLOGIES
Technical expertise in biotechnology, engineering and other pertinent fields
More Publications
2014-2018 World Animal Health Market Dynamics, Trends and Leading Suppliers' Strategies, Marketing Tactics, and Technological Know-How
US$ 3,880.00
November 2014
110 pages
2015 CompetitiveWatch Paint and Coatings: Leading Suppliers Strategic Directions, Marketing Tactics and Technological Know-How
US$ 2,800.00
October 2015
134 pages
CompetitiveWatch 2014: Monsanto - Technological Know-How, Marketing Tactics and Strategic Directions in the Global Agrochemical Market
US$ 360.00
February 2014
-
